Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimecon 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Himalaya Meditek Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimecon 1mg/500mg Tablet SR

DiabetaComb 1mg/500mg Extended-Release tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. DiabetaComb should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood glucose response. Continuous use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, including a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Prompt glucose intake (e.g., sugary snacks, juice) is essential. Alcohol consumption should be limited due to its hypoglycemic effect. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring, along with blood tests to assess blood cell counts and liver function, may be recommended.

Primary Ingredients of Glimecon 1mg/500mg Tablet SR

No text provided to rephrase.

Uses of Glimecon 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimecon 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Glimecon 1mg/500mg Extended-Release Tablets should be administered with a meal.

Common Side effects of Glimecon 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimecon 1mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimecon 1mg/500mg Sustained-Release tablets should be administered with a meal.

How Glimecon 1mg/500mg Tablet SR works:

Glimecon SR tablets (1mg glimepiride/500mg metformin) combine two anti-diabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimecon 1mg/500mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimecon 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Extended-release Glimepiride/Metformin 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimecon 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimecon 1mg/500mg SR tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimecon 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A low initial dose is typically prescribed for individuals with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimecon 1mg/500mg Tablet SR :

Should you forget a Glimecon 1mg/500mg SR tablet, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimecon 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimecon 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Glimecon 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimecon 1mg/500mg Tablet SR and seek immediate medical attention.
Glimecon 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glimepiride/metformin tablets (1mg/500mg SR) may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimepiride/Metformin 1mg/500mg extended-release tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glimecon 1mg/500mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimecon 1mg/500mg SR tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimecon 1mg/500mg Tablet...
33
MRP 40
17% off